Hansa Biopharma Q1: Hansa continues to make progress
Research Note
2021-04-22
08:43
Redeye’s early key take-away is that Hansa’s European Ideflirix launch is well underway and that Hansa continues to make trial progress.
JU
Johan Unnerus
Disclosures and disclaimers